Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 187

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Neuroendocrine differentiation of prostate cancer leads to PSMA suppression

Open access
Bakht, Martin K, Derecichei, Iulian, Li, Yinan, Ferraiuolo, Rosa-Maria, Dunning, Mark, Oh, So Won, Hussein, Abdulkadir, Youn, Hyewon, Stringer, Keith F, Jeong, Chang Wook, Cheon, Gi Jeong, Kwak, Cheol, Kang, Keon Wook, Lamb, Alastair D, Wang, Yuzhuo, Dong, Xuesen, Porter, Lisa A · 2019 · Endocrine-Related Cancer

Abstract

Prostate-specific membrane antigen (PSMA) is overexpressed in most prostate adenocarcinoma (AdPC) cells and acts as a target for molecular imaging. However, some case reports indicate that PSMA-targeted imaging could be ineffectual for delineation of neuroendocrine (NE) prostate cancer (NEPC) lesions due to the suppression of the PSMA gene (FOLH1). These same reports suggest that targeting somatostatin receptor type 2 (SSTR2) could be an alternative diagnostic target for NEPC patients. This study evaluates the correlation between expression of FOLH1, NEPC marker genes and SSTR2. We evaluated the transcript abundance for FOLH1 and SSTR2 genes as well as NE markers across 909 tumors. A significant suppression of FOLH1 in NEPC patient samples and AdPC samples with high expression of NE marker genes was observed. We also investigated protein alterations of PSMA and SSTR2 in an NE-induced cell line derived by hormone depletion and lineage plasticity by loss of p53. PSMA is suppressed following NE induction and cellular plasticity in p53-deficient NEPC model. The PSMA-suppressed cells have more colony formation ability and resistance to enzalutamide treatment. Conversely, SSTR2 was only elevated following hormone depletion. In 18 NEPC patient-derived xenograft (PDX) models we find a significant suppression of FOLH1 and amplification of SSTR2 expression. Due to the observed FOLH1-supressed signature of NEPC, this study cautions on the reliability of using PMSA as a target for molecular imaging of NEPC. The observed elevation of SSTR2 in NEPC supports the possible ability of SSTR2-targeted imaging for follow-up imaging of low PSMA patients and monitoring for NEPC development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/erc-18-0226

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 187

Metadata

Authors
Bakht, M. K., Derecichei, I., Li, Y., Ferraiuolo, R.-M., Dunning, M., Oh, S. W., Hussein, A., Youn, H., Stringer, K. F., Jeong, C. W., Cheon, G. J., Kwak, C., Kang, K. W., Lamb, A. D., Wang, Y., Dong, X., & Porter, L. A.
Venue
Endocrine-Related Cancer
Published
2019-02
Volume
26
Issue
2
Pages
131-146
ISSN
  • 1351-0088 (ISSN-L)
  • 1479-6821
OpenAlex
W2896060946
Cited by
187
References
7
FWCI
6.43
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroendocrine differentiation of prostate cancer leads to PSMA suppression. https://app.cochat.ai/papers/10.1530/erc-18-0226
The paper
Bakht, M. K., Derecichei, I., Li, Y., Ferraiuolo, R.-M., Dunning, M., Oh, S. W., Hussein, A., Youn, H., Stringer, K. F., Jeong, C. W., Cheon, G. J., Kwak, C., Kang, K. W., Lamb, A. D., Wang, Y., Dong, X., & Porter, L. A. (2019). Neuroendocrine differentiation of prostate cancer leads to PSMA suppression. Endocrine-Related Cancer. https://doi.org/10.1530/erc-18-0226

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.